Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 1
2017 2
2019 1
2020 4
2021 3
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
The potential of CAR T cell therapy for prostate cancer.
Wolf P, Alzubi J, Gratzke C, Cathomen T. Wolf P, et al. Among authors: alzubi j. Nat Rev Urol. 2021 Sep;18(9):556-571. doi: 10.1038/s41585-021-00488-8. Epub 2021 Jul 8. Nat Rev Urol. 2021. PMID: 34239139 Review.
CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells.
Hammad R, Alzubi J, Rhiel M, Chmielewski KO, Mosti L, Rositzka J, Heugel M, Lawrenz J, Pennucci V, Gläser B, Fischer J, Schambach A, Moritz T, Lachmann N, Cornu TI, Mussolino C, Schäfer R, Cathomen T. Hammad R, et al. Among authors: alzubi j. Int J Mol Sci. 2024 Jan 12;25(2):985. doi: 10.3390/ijms25020985. Int J Mol Sci. 2024. PMID: 38256061 Free PMC article.
Automated generation of gene-edited CAR T cells at clinical scale.
Alzubi J, Lock D, Rhiel M, Schmitz S, Wild S, Mussolino C, Hildenbeutel M, Brandes C, Rositzka J, Lennartz S, Haas SA, Chmielewski KO, Schaser T, Kaiser A, Cathomen T, Cornu TI. Alzubi J, et al. Mol Ther Methods Clin Dev. 2020 Dec 25;20:379-388. doi: 10.1016/j.omtm.2020.12.008. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2020. PMID: 33575430 Free PMC article.
Modeling MyD88 Deficiency In Vitro Provides New Insights in Its Function.
Craig-Mueller N, Hammad R, Elling R, Alzubi J, Timm B, Kolter J, Knelangen N, Bednarski C, Gläser B, Ammann S, Ivics Z, Fischer J, Speckmann C, Schwarz K, Lachmann N, Ehl S, Moritz T, Henneke P, Cathomen T. Craig-Mueller N, et al. Among authors: alzubi j. Front Immunol. 2020 Dec 23;11:608802. doi: 10.3389/fimmu.2020.608802. eCollection 2020. Front Immunol. 2020. PMID: 33424861 Free PMC article.
TALE-PvuII fusion proteins--novel tools for gene targeting.
Yanik M, Alzubi J, Lahaye T, Cathomen T, Pingoud A, Wende W. Yanik M, et al. Among authors: alzubi j. PLoS One. 2013 Dec 5;8(12):e82539. doi: 10.1371/journal.pone.0082539. eCollection 2013. PLoS One. 2013. PMID: 24349308 Free PMC article.
Biodegradable Nanocarriers Resembling Extracellular Vesicles Deliver Genetic Material with the Highest Efficiency to Various Cell Types.
Tarakanchikova Y, Alzubi J, Pennucci V, Follo M, Kochergin B, Muslimov A, Skovorodkin I, Vainio S, Antipina MN, Atkin V, Popov A, Meglinski I, Cathomen T, Cornu TI, Gorin DA, Sukhorukov GB, Nazarenko I. Tarakanchikova Y, et al. Among authors: alzubi j. Small. 2020 Jan;16(3):e1904880. doi: 10.1002/smll.201904880. Epub 2019 Dec 16. Small. 2020. PMID: 31840408
15 results